Founder of GroundSwell Advisors LLC, Joseph P. Hagan currently is President, Chief Executive Officer & Director at Regulus Therapeutics, Inc. Mr. Hagan is also on the board of Aurinia Pharmaceuticals, Inc.

In the past Mr. Hagan was Acting Chief Executive Officer at Unity Pharma, Head-Corporate Development at Amgen, Inc. and Managing Director at Amgen Ventures LLC (a subsidiary of Amgen, Inc.), Director at Accelerator Services Corp., Chief Financial & Business Officer, Executive VP at Orexigen Therapeutics, Inc. and Partner at GroundSwell Advisors LLC.

Joseph P. Hagan received an MBA from Northeastern University and an undergraduate degree from the University of California San Diego.